![](https://investorshub.advfn.com/uicon/591374.png?cb=1485035485)
Saturday, January 28, 2017 12:06:27 AM
First, the efficacy test. We all know what GWPH and AXIM did after efficacy results dropped.
Second, OWCP will drop another 8-K with details of the consulting agreements with the 3 mystery MMJ States. Sure, the agreements are likely for nominal cash value. However, what is the likelihood that a new MMJ state like CA or MA will take a look at OWCP's research and decide that delivery systems like creams or sublingual tablets are preferred over smoking or oils? Can you imagine if CA announced that it's MMJ program would only allow for CBD/HTC compounds to be used via creams or sublingual tablets?
No reputable, thoughtful doctor is going to tell a patient to "take two puffs and call me in the morning". Yes, maybe for patients who just need pain management. But for everyone else, especially children, the delivery method is key. OWCP has 2 proprietary delivery methods ready to go!
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM